21st.BIO A/S

Public limited companyCVR 41554908SøborgActive

21st.BIO A/S is a public limited company, based in Søborg, active in other technical consultancy, founded in 2020. The company made a loss in both 2024 and 2025, most recently DKK 129.7m. With 44 employees, the company is about 22 times larger than the industry median. Equity fell to DKK 202.7m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 16.1m+35.7% vs. 2024
Net profit−DKK 129.7m−211.5% vs. 2024
EquityDKK 202.7m−38.6% vs. 2024
Employees44latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 36% (2024 → 2025), to DKK 16.1m.
  • The loss grew: from DKK 41.6m to DKK 129.7m (2024 → 2025).
  • Equity fell 39% (2024 → 2025), to DKK 202.7m.

Employees

  • 3 more employees than a year earlier: 44 (07/2026) against 41 (07/2025).

Management and owners, last 24 months

  • New in management: Jose Arnau Martinez (director, 06/01/2025), Henrik Marcus Geertz-Hansen (director, 06/01/2025) and Anders Bendsen Spohr (chair of the board, 06/02/2025).
  • Stepped down: Søren Møller (chair of the board, 06/02/2025), Per Falholt (director, 06/01/2025) and Thorvald Uhrskov Ullum (director, 06/01/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2025 · amounts in DKK thousand

Equity and net profit

−DKK 200m−DKK 100mDKK 0DKK 100mDKK 200mDKK 300m20212022202320242025
EquityNet profit
Financial figures for 21st.BIO A/S
20212022202320242025Change
Revenuenot statednot statednot statednot statednot stated–
Gross profit−19,455−21,93111,61311,85516,086+35.7%
Operating profit (EBIT)−22,264−55,447−44,433−60,052−151,745−152.7%
Profit before tax–−54,209−48,398−60,928−165,124−171%
Net profit−21,796−36,612−42,260−41,629−129,664−211.5%
Total assets33,964329,388425,788444,993368,251−17.2%
Equity23,854262,616294,809330,332202,680−38.6%
Liabilities10,11012,587––––
Cash and cash equivalents24,30349,28788,70691,43729,435−67.8%
Average number of employees311325558+5.5%

Source: annual reports filed with the Danish Business Authority (XBRL). Group figures; change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 25m−DKK 20m−DKK 15m−DKK 10m−DKK 5mDKK 0DKK 5mDKK 10mDKK 15m20212022202320242025
Gross profitMedian, the industry (440 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Loss for 5 years in a row

    Net result has been negative in 2021–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 39% from 2024 to 2025 (DKK 330.3m to DKK 202.7m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

5 financial years
Annual reports for 21st.BIO A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202526/06/2026The groupPDF not statedXBRL
202401/01/2024 – 31/12/202430/06/2025The groupPDFXBRL
202301/01/2023 – 31/12/202313/05/2024The groupPDFXBRL
202201/01/2022 – 31/12/202223/05/2023The companyPDFXBRL
202101/08/2020 – 31/12/202127/05/2022The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0102030405008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

440 companies in the database

Comparison with the other companies in other technical consultancy based on the latest financial year.

Gross profitDKK 16.1mNo. 40 of 439
Better than 91% of the companies in the industry
EquityDKK 202.7mNo. 3 of 440
Better than 100% of the companies in the industry
Number of employees44No. 12 of 440
Better than 97% of the companies in the industry

Industry median: gross profit DKK 1.9m, net profit DKK 210k, equity DKK 874k, 2 employees.

DKK 100kDKK 645kDKK 4.2mDKK 26.8mDKK 92.9mHere
Distribution of gross profit for 401 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 3,867of 9,892
Better than 61%
No. 199of 9,922
Better than 98%
Same industry and 20–49 employees32 companies in the comparison
No. 23of 32
Better than 29%
No. 1of 32
Better than 100%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 2,634of 33,588
Better than 92%
No. 405of 33,687
Better than 99%
All companies of type A/S18,025 companies in the comparison
No. 6,903of 17,786
Better than 61%
No. 1,425of 18,024
Better than 92%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Other technical consultancy
Gross profit
  1. 21st.BIO A/SDKK 16.1m
  2. Nordomatic A/SDKK 172.8m
  3. NRGi Rådgivning A/SDKK 113.6m
Net profit
  1. 21st.BIO A/S−DKK 129.7m
  2. Nordomatic A/SDKK 37.7m
  3. NRGi Rådgivning A/S−DKK 26.3m
Equity
  1. 21st.BIO A/SDKK 202.7m
  2. Nordomatic A/SDKK 102.5m
  3. NRGi Rådgivning A/SDKK 28.6m
Employees
  1. 21st.BIO A/S44
  2. Nordomatic A/S173
  3. NRGi Rådgivning A/S183

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
21st.BIO A/S

Management

10 active registrations

Executive management

Executive management at 21st.BIO A/S
NameRoleAppointed
Thomas Günther SchmidtDirector01/08/2020
Thomas Troelsgaard KabelDirector01/11/2021
Mikael BechsgaardDirector01/11/2023
Jose Arnau MartinezDirector06/01/2025
Henrik Marcus Geertz-HansenDirector06/01/2025

Board of directors

Board of directors at 21st.BIO A/S
NameRoleAppointed
Thomas Günther SchmidtBoard member01/08/2020
Claus Crone FuglsangBoard member30/09/2022
Thomas GrotkjærBoard member05/09/2023
Thomas Dal Stenfeldt BatchelorBoard member05/09/2023
Anders Bendsen SpohrChair of the board06/02/2025
Founders
Steen Riisgaard, Lille Frederikslund Invest ApS, Momentum Techinvest ApS
Former management (8)
Former management at 21st.BIO A/S
NameRoleAppointedResigned
Steen RiisgaardChair of the board01/08/202019/11/2020
Per FalholtBoard member01/08/202017/12/2021
Niels Jørgen KornerupBoard member23/11/202017/12/2021
Anders Bendsen SpohrBoard member17/12/202105/09/2023
Søren MøllerChair of the board17/12/202106/02/2025
Per FalholtDirector01/01/202206/01/2025
Thorvald Uhrskov UllumDirector10/08/202206/01/2025
Amy Louise ByrickBoard member30/09/202205/09/2023

Signing rule: Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem , eller af bestyrelsesformanden i forening med en direktør eller af den samlede bestyrelse.

Address and production units

2 active production units

Sydmarken 42
2860 Søborg

Gladsaxe Municipality · Postcode 2860

Production units
Production unitAddressEmployeesP number
21st.bio LaboratoryOle Maaløes Vej 3, 2200 København N441027530512
21st.BIO A/SSydmarken 42, 2860 Søborg11028498396

Purpose

Selskabets formål er rådgivning om, investering i og udvikling af industrielle biotech-løsninger samt aktiviteter, der efter bestyrelsens skøn er forbundet dermed.

The purpose is quoted from the register in Danish.

Changes year by year

64 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20257 changesaccounts 1 · management 6
  • Annual report for 2024 published
  • Anders Bendsen Spohr appointed chair of the board
  • Søren Møller stepped down as chair of the board
  • Jose Arnau Martinez appointed director
  • Henrik Marcus Geertz-Hansen appointed director
  • Thorvald Uhrskov Ullum stepped down as director
  • Per Falholt stepped down as director
20244 changescapital 1 · ownership 2 · accounts 1
  • Share capital changed from 12,058,092 DKK to 16,700,348 DKK
  • Novo Holdings A/S registered as owner (33.33%)
  • Novo Holdings A/S is no longer registered as owner
  • Annual report for 2023 published
20239 changesmanagement 5 · capital 1 · ownership 2 · accounts 1
  • Mikael Bechsgaard appointed director
  • Thomas Dal Stenfeldt Batchelor appointed board member
  • Thomas Grotkjær appointed board member
  • Amy Louise Byrick stepped down as board member
  • Anders Bendsen Spohr stepped down as board member
  • Share capital changed from 10,099,334 DKK to 12,058,092 DKK
  • Novo Holdings A/S registered as owner (50%)
  • Novo Holdings A/S is no longer registered as owner
  • Annual report for 2022 published
202214 changescapital 1 · management 4 · ownership 5 · merger 1 · address 2 · accounts 1
  • Share capital changed from 3,229,994 DKK to 10,099,334 DKK
  • Claus Crone Fuglsang appointed board member
  • Amy Louise Byrick appointed board member
  • Novo Holdings A/S registered as owner (33.33%)
  • Momentum Techinvest ApS registered as owner (5%)
  • NOVOZYMES A/S registered as owner (33.33%)
  • Merger registered in CVR
  • Novo Holdings A/S is no longer registered as owner
  • Momentum Techinvest ApS is no longer registered as owner
  • Moved to Sydmarken 42, 2860 Søborg
  • Thorvald Uhrskov Ullum appointed director
  • Annual report for 2021 published
  • Moved to Teknikerbyen 5, 2, Søllerød, 2830 Virum
  • Per Falholt appointed director
202113 changescapital 2 · management 5 · ownership 6
  • Share capital changed from 950,000 DKK to 3,229,994 DKK
  • Anders Bendsen Spohr appointed board member
  • Søren Møller appointed chair of the board
  • Niels Jørgen Kornerup stepped down as board member
  • Per Falholt stepped down as board member
  • Novo Holdings A/S registered as owner (66.67%)
  • Momentum Techinvest ApS registered as owner (25%)
  • Momentum Techinvest ApS is no longer registered as owner
  • Thomas Troelsgaard Kabel appointed director
  • Momentum Techinvest ApS registered as owner (100%)
  • LILLE FREDERIKSLUND INVEST ApS is no longer registered as owner
  • Momentum Techinvest ApS is no longer registered as owner
  • Share capital changed from 450,000 DKK to 950,000 DKK
202016 changesname 1 · management 6 · ownership 8 · founded 1
  • Name changed from Copenhagen Bio Partners A/S to 21st.BIO A/S
  • Niels Jørgen Kornerup appointed board member
  • Steen Riisgaard stepped down as chair of the board
  • Momentum Techinvest ApS registered as owner (50%)
  • LILLE FREDERIKSLUND INVEST ApS registered as owner (50%)
  • Steen Riisgaard is no longer registered as owner
  • LILLE FREDERIKSLUND INVEST ApS is no longer registered as owner
  • Momentum Techinvest ApS is no longer registered as owner
  • Registered as Copenhagen Bio Partners A/S
  • Thomas Günther Schmidt appointed director
  • Per Falholt appointed board member
  • Thomas Günther Schmidt appointed board member
  • Steen Riisgaard appointed chair of the board
  • LILLE FREDERIKSLUND INVEST ApS registered as owner (33.33%)
  • Momentum Techinvest ApS registered as owner (33.33%)
  • Steen Riisgaard registered as owner (33.33%)

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction